Clinical Trials Arena5h
Neurocrine Biosciences debuts new data for effectiveness of Ingrezza
Of the 103 patients who completed the Phase III trial, more than half saw remission from a drug-induced condition.
Clinical Trials Arena11h
Regenxbio’s DMD gene therapy drives 122.3% biomarker uptick in three-year-old
Regenxbio has reported positive interim data from the Phase I/II portion of its Affinity Duchenne study, which is examining ...
Clinical Trials Arena8h
NACE to launch trial in Australia for young people with hay fever
NACE has collaborated with 17 Australian general practices and allergy clinics to launch the ARISE trial for young people with hay fever.
Clinical Trials Arena9h
Funding drought: how can biotech and biopharma keep trials running?
Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.
clinicaltrialsarena22h
Omnipod 5 improves glycaemic levels in people transitioning from daily injections
Results from the trial showed that patients started with an average HbA1c level of 8.1% and dropped to 7.2%. Credit: Shutterstock / Rost9. Individuals with type 1 diabetes (T1D) have demonstrated ...
clinicaltrialsarena22h
Roche’s discontinued Alzheimer’s drug shows signs of preventing onset
The Knight Family DIAN-TU platform trial was initiated in 2012. Image credit: Shutterstock / Orawan Pattarawimonchai. Roche’s discontinued Alzheimer’s disease drug has shown signs that it could ...